bioRxivImmunology
Mapping SARS-CoV-2 antigenic relationships and serological responses
S. H. Wilks, B. Muhlemann, X. Shen, S. Tureli, E. B. LeGresley, A. Netzl, M. A. Caniza, J. N. Chacaltana-Huarcaya, V. M. Corman, X. Daniell, M. B. Datto, F. S. Dawood, T. N. Denny, C. Drosten, R. A. M. Fouchier, P. J. Garcia, P. J. Halfmann, A. Jassem, L. M. Jeworowski, T. C. Jones, Y. Kawaoka, F. Krammer, C. McDanal, R. Pajon, V. Simon, , D. J. Smith
Abstract
During the SARS-CoV-2 pandemic, multiple variants escaping pre-existing immunity emerged, causing concerns about continued protection. Here, we use antigenic cartography to analyze patterns of cross-reactivity among a panel of 21 variants and 15 groups of human sera obtained following primary infection with 10 different variants or after mRNA-1273 or mRNA-1273.351 vaccination. We find antigenic differences among pre-Omicron variants caused by substitutions at spike protein positions 417, 452, 484, and 501. Quantifying changes in response breadth over time and with additional vaccine doses, our results show the largest increase between 4 weeks and >3 months post-2nd dose. We find changes in immunodominance of different spike regions depending on the variant an individual was first exposed to, with implications for variant risk assessment and vaccine strain selection. One sentence summaryAntigenic Cartography of SARS-CoV-2 variants reveals amino acid substitutions governing immune escape and immunodominance patterns.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones
N. S. Lima, M. Musayev, … P. D. Kwong·bioRxiv·Mar 28, 2022
- Post-vaccination Omicron infections induce broader immunity across antigenic space than prototype mRNA COVID-19 booster vaccination or primary infection
W. Wang, S. Lusvarghi, … C. D. Weiss·bioRxiv·Jul 5, 2022
- Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting.
Jeffrey Seow, George C.E. Jefferson, … Katie J. Doores·PLoS PathogensPeer-reviewed·Nov 18, 2024
- Omicron BA.1 and BA.2 are antigenically distinct SARS-CoV-2 variants
A. Z. Mykytyn, M. Rissmann, … B. Haagmans·bioRxiv·Feb 23, 2022
- Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein after infection and/or vaccination
M. E. Garrett, J. G. Galloway, … J. M. Overbaugh·bioRxiv·Oct 5, 2021
- Bioinformatic analysis of B and T cell epitopes from SARS-CoV-2 Spike, Membrane and Nucleocapsid proteins as a strategy to assess possible cross-reactivity between emerging variants, including Omicron, and other human coronaviruses
Diana Laura Pacheco-Olvera, Stephanie Saint Remy-Hernández, … Constantino III Roberto López-Macías·bioRxiv·Feb 16, 2022